The 20 Best Large-Cell Lung Carcinoma Doctors in New York, US

. Dr. Korytko is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Throat Cancer, and Small Cell Lung Cancer (SCLC).

. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

. Dr. Allerton is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

. Dr. Parylo is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC).

. Dr. Varsos is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Angiosarcoma, and EGFR Positive Lung Cancer.

. Dr. Chukiert is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Pneumonia.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Kenneth D. Gold, MD joined Northwell Health Physician Partners and the Northwell Health Cancer Institute as an attending physician of the Department of Medicine.Kenneth D. Gold, MD graduated magna cum laude from Amherst College. He earned his medical degree at Baylor College of Medicine in Houston, Texas, and then trained in Internal Medicine at George Washington University, where he also served as Chief Medical Resident. His fellowship in Hematology and Medical Oncology was completed at Columbia Presbyterian Medical Center. Dr. Gold is board-certified in Internal medicine, Hematology and medical Oncology.Previously Chief of Hematology and Medical Oncology at Good Samaritan Hospital, West Islip, and an attending physician at Southside Hospital, Dr. Gold has been a leader in Suffolk County in the diagnosis and treatment of cancer and blood diseases since 1983. He served for many years as the Chair of the Transfusion Committees at both Good Samaritan Hospital Medical Center and Southside Hospital. Dr. Gold is a member of the American Society of Clinical Oncology. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Inflammatory Breast Cancer.

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Ronnie Luyun is an Oncologist and an Internal Medicine provider in Albany, New York. Dr. Luyun has been practicing medicine for over 30 years and is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Osteosarcoma, Chondrosarcoma, Paget Disease of the Breast, and Ewing Sarcoma. Dr. Luyun is currently accepting new patients.

Eugene Shostak is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Flushing, New York. Dr. Shostak is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Tracheobronchomalacia, Acquired Tracheomalacia, Small Cell Lung Cancer (SCLC), Advanced Bronchoscopy, and Gastrostomy. Dr. Shostak is currently accepting new patients.

Duncan Savage is a Radiation Oncologist in Troy, New York. Dr. Savage has been practicing medicine for over 45 years and is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Endometrial Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Savage is currently accepting new patients.

Kyle Denniston is a Radiation Oncologist in Albany, New York. Dr. Denniston has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Denniston is currently accepting new patients.

Alan Schaffer is an Internal Medicine specialist and a Bariatric Medicine provider in Albany, New York. Dr. Schaffer has been practicing medicine for over 39 years and is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Atypical Pneumonia, Obstructive Sleep Apnea, Emphysema, and Bullae. Dr. Schaffer is currently accepting new patients.

Jamie Chaft is an Oncologist in New York, New York. Dr. Chaft is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Chaft is currently accepting new patients.

Helena Yu is an Oncologist in New York, New York. Dr. Yu is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Yu is currently accepting new patients.

Gregory Riely is an Oncologist in New York, New York. Dr. Riely is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Thymic Epithelial Tumor, Tissue Biopsy, and Liver Embolization. Dr. Riely is currently accepting new patients.

Joshua Sabari is an Oncologist in New York, New York. Dr. Sabari is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Tissue Biopsy, and Thrombectomy.

Dr. Stoopler received his Bachelor of Science degree from Tulane University in 1971 and his medical degree from Cornell University Medical College in 1975. He completed his residency at North Shore University Hospital/Memorial Hospital and his oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York City before joining the Columbia faculty in 1980. He is a Fellow of the American College of Physicians and a member of the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the International Society of Gastrointestinal Oncology, the American Federation for Clinical Research and the Southwest Oncology Group. Dr. Stoopler is involved in patient care, clinical research and teaching on the medical oncology service. Dr. Stoopler is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Pleuropulmonary Blastoma, and Gamma Knife Radiosurgery.

Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Salpingo-Oophorectomy.